| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $86.1M | +0.4% | +2.7% |
| Cost of Revenue | $42.0M | +1.9% | -0.8% |
| R&D Expense | $8.2M | +0.7% | +5.6% |
| SG&A Expense | $19.4M | +7.4% | +0.2% |
| Operating Income | $4.1M | +12.2% | +109.3% |
| Pre-tax Income | $1.4M | +93.7% | +154.8% |
| Income Tax | -$4.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $19.9M | +62.2% | +132.0% |
| Accounts Receivable | $56.8M | +0.6% | +0.2% |
| Inventory | $351K | -20.9% | -62.0% |
| Current Assets | $102.6M | +13.6% | +12.0% |
| Total Assets | $399.4M | +2.4% | -0.5% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $28.1M | — | — |
| Capital Expenditures | $839K | — | — |
| Investing Cash Flow | -$10.9M | — | — |
| Financing Cash Flow | -$9.6M | — | — |
| Free Cash Flow | $27.3M | — | — |
| -125.8% |
| -157.9% |
| Net Income | $5.6M | +117.1% | +157.1% |
| EPS (Basic) | $0.37 | +117.6% | +156.1% |
| EPS (Diluted) | $0.37 | +117.6% | +156.1% |
| $53.7M |
| +7.1% |
| +5.4% |
| Long-term Debt | $164.3M | -1.1% | -6.8% |
| Total Liabilities | $219.1M | +1.0% | -4.3% |
| Stockholders' Equity | $180.4M | +4.1% | +4.5% |